The incidence and natural history of dasatinib complications in the treatment of chronic myeloid leukemiaLucy C. Fox, Andrew Grigg, Rebecca Cleary et al.|Blood Advances|2017Cited by 42
The natural history of vascular and other complications in patients treated with nilotinib for chronic myeloid leukemiaAdrian Minson, Andrew Grigg, Katherine D. Cummins et al.|Blood Advances|2019Cited by 26